J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M700264-JLR200 on December 10, 2007

Papers In Press, published online ahead of print March 1, 2008
J. Lipid Res., doi:10.1194/jlr.M700264-JLR200
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700264-JLR200v1
49/3/510    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Gugiu, B. G.
Right arrow Articles by Watson, A. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gugiu, B. G.
Right arrow Articles by Watson, A. D.
Journal of Lipid Research, Vol. 49, 510-520, March 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

Protein targets of oxidized phospholipids in endothelial cellsboxs

B. Gabriel Gugiu*, Kevin Mouillesseaux*, Victoria Duong{dagger}, Tabitha Herzog{dagger}, Avetis Hekimian{dagger}, Lukasz Koroniak§, Thomas M. Vondriska** and Andrew D. Watson1,{dagger}

* Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095
{dagger} Department of Medicine/Cardiology, University of California, Los Angeles, Los Angeles, CA 90095
§ Department of Chemistry/Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095
** Department of Anesthesiology/Medicine, University of California, Los Angeles, Los Angeles, CA 90095

boxs The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of sixteen figures and one table.

Published, JLR Papers in Press, December 10, 2007.

1 To whom correspondence should be addressed. e-mail: awatson{at}mednet.ucla.edu

Oxidation products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidylcholine (Ox-PAPC) are found in atherosclerotic lesions, apoptotic cells, and oxidized LDL and stimulate human aortic endothelial cells (HAECs) to produce inflammatory cytokines, leukocyte chemoattractants, and coagulation factors. This regulation is thought to be a receptor-mediated process in which oxidized phospholipids activate specific receptors on HAECs to evoke an inflammatory response. To characterize the HAEC proteins with which oxidized phospholipids interact, a biotinylated PAPC analog, 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidyl-(N-biotinylethanolamine) (PAPE-N-biotin), was synthesized. Oxidation of PAPE-N-biotin in air generated a mixture of biotin-labeled oxidized lipids analogous to Ox-PAPC. Ox-PAPE-N-biotin, like Ox-PAPC, induced interleukin-8 (IL-8) protein synthesis and stimulated IL-8, low density lipoprotein receptor, heme oxygenase-1, and activating transcription factor-3 mRNA expression in HAECs. After treatment of HAECs with Ox-PAPE-N-biotin, the cellular proteins were isolated and separated by SDS-PAGE. Western analysis with streptavidin-HRP demonstrated at least 20 different biotinylated HAEC proteins to which the Ox-PAPE-N-biotin was associated, which were not detected with unoxidized PAPE-N-biotin treatment. This work suggests that oxidized phospholipids, such as those found in oxidized LDL, apoptotic cells, and atherosclerotic lesions, form tight interactions with specific endothelial cell proteins, which may be responsible for the inflammatory response. Identification of these putative oxidized phospholipid targets may reveal therapeutic targets to modulate inflammation and atherosclerosis.

Supplementary key words atherosclerosis • inflammation • lipid peroxidation • mass spectrometry • lipoproteins • interleukin-8 • monocyte chemoattractant protein-1 • biotinylation

Abbreviations: BODIPY, dipyromethene boron difluoride; CKAP4, cytoskeleton-associated protein-4; HAEC, human aortic endothelial cell; IL-8, interleukin-8; Ox-X, oxidation products of X; PAPC, 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidylcholine; PAPE, 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidylethanolamine; PAPE-N-biotin, 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidyl-(N-biotinylethanolamine); PEIPC, 1-palmitoyl-2-(5,6-epoxyisoprostane E2)-sn-glycero-3-phosphatidylcholine; PEIPE-N-biotin, 1-palmitoyl-2-(5,6-epoxyisoprostane E2)-sn-glycero-3-phosphatidyl-(N-biotinylethanolamine); PGPC, 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphatidylcholine; POVPC, 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphatidylcholine; PVDF, polyvinylidene difluoride; sulfo-NHS-biotin, biotin ester of N-hydroxysuccinimide sulfonate






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.